Otsuka Files NDA for Centanafadine, a First-in-Cla...
Category : Clinical Trial Update 27 November 2025Otsuka has taken a major step in ADHD innovation. The company has filed a New Drug Application (NDA)...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
NeuroSense Secures FDA Clearance to Launch Pivotal...
Category : Clinical Trial Update 27 November 2025NeuroSense Therapeutics has hit a major milestone. The FDA has cleared the company to begin its pivo...
Lighthouse Pharmaceuticals Showcases New Precision...
Category : Clinical Trial Update 27 November 2025Alzheimer’s research is shifting toward precision medicine, and Lighthouse Pharmaceuticals is...
Bayer Posts Strong Phase III Results for Asundexia...
Category : Clinical Trial Update 26 November 2025Bayer has shared encouraging topline results from its OCEANIC-STROKE Phase III trial, testing asunde...
Viking Therapeutics to Join Piper Sandler’s 37th A...
Category : Clinical Trial Update 26 November 2025Viking Therapeutics is stepping into the spotlight this December. The metabolic-drug developer will...
Latest Newsletter Post
-
Lighthouse Pharmaceuticals Showcase..
27 November 2025
-
NeuroSense Secures FDA Clearance to..
27 November 2025
-
Otsuka Files NDA for Centanafadine,..
27 November 2025
-
Cornell Launches New Study on Once-..
26 November 2025
-
Viking Therapeutics to Join Piper S..
26 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com